Thoughts on the impact of partnerships – a word from our director
Bold collaborations. Transforming Health: this is how we describe IHI, and this month I had the opportunity to showcase the importance and impact of partnerships – bringing together researchers, public bodies such as regulators, civil society and patient organisations with industry to address difficult and important health challenges for Europe – at a conference on the future of the life sciences and health organised by the Polish presidency of the EU and the LifeScience Cluster Kraków.
The key to success is to recognise and leverage the complementary strength of different actors, for instance by aligning cutting-edge research with industrial engineering capabilities and processes for translating innovation into impact. Including people with the lived experience of disease allows projects to do science differently and enables completely new approaches to research built on deep partnerships.
The work of IHI and IMI projects to strengthen Europe’s capabilities for clinical trials are a great example of what these partnerships can achieve. As we read in this newsletter, our projects are enabling innovative new methodologies and working with experts, patient organisations and philanthropic foundations to build the networks that give patients in Europe more opportunities to take part in Europe-based clinical trials. In addition, ensuring that the EU remains competitive as a destination for running clinical trials is critical for European competitiveness and for giving people early access to innovative treatments.
Niklas Blomberg, IHI Executive Director
The key to success is to recognise and leverage the complementary strength of different actors, for instance by aligning cutting-edge research with industrial engineering capabilities and processes for translating innovation into impact. Including people with the lived experience of disease allows projects to do science differently and enables completely new approaches to research built on deep partnerships.
The work of IHI and IMI projects to strengthen Europe’s capabilities for clinical trials are a great example of what these partnerships can achieve. As we read in this newsletter, our projects are enabling innovative new methodologies and working with experts, patient organisations and philanthropic foundations to build the networks that give patients in Europe more opportunities to take part in Europe-based clinical trials. In addition, ensuring that the EU remains competitive as a destination for running clinical trials is critical for European competitiveness and for giving people early access to innovative treatments.
Niklas Blomberg, IHI Executive Director
Read the updated draft topic texts for IHI call 11
Updated drafts of the topic texts are now available on the IHI website – get ahead of the game and start networking and working on your proposal now!
Sign up for the IHI Call Days for call 11
These online info sessions, which cover all call topics as well as IHI’s rules and procedures, are key to understanding what you need to do to prepare a strong proposal. The sessions run from 23 to 30 June.
Making Europe more attractive for conducting clinical trials
In diverse ways, IHI and IMI projects are enhancing Europe’s attractiveness as a destination for conducting clinical trials, and so contributing Europe’s competitiveness in the sector.
Paper highlights strong IMI/IHI contribution to paediatric research
IMI and IHI projects are boosting paediatric research and development, writes IHI’s Nathalie Seigneuret in Frontiers in Medicine.
New project plans to revolutionise treatment for Crohn’s disease
IHI project INTERCEPT aims to transform Crohn’s disease from an incurable condition to one that could be managed and even potentially prevented.
PERISCOPE studies pertussis vaccine regimens in pregnancy and infants
The Gambian Pertussis Study (GaPs) is the first study to provide comprehensive immunological data comparing vaccine regimens in pregnancy and infancy.
Meet IHI at HLTH Europe 2025
IHI will have a booth at the HTLTH Europe 2025 event in Amsterdam on 16-19 June. The event aims to showcase healthcare innovation in Europe.
Catch up on our event on IMI/IHI’s impact on cancer
The recording of our event on how IMI and IHI projects are making a difference in cancer is now available online.